NCT04716699View on ClinicalTrials.gov

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

December 26, 2021

Study Completion Date

January 24, 2022

Conditions
Glioblastoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood and tumor samples

DRUG

Lidocaine

Given IV

PROCEDURE

Resection

Undergo surgical resection per standard of care

Trial Locations (1)

95817

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Kiarash Shahlaie, M.D., Ph.D.

OTHER

NCT04716699 - Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma | Biotech Hunter | Biotech Hunter